THE REFRACTORY OVERACTIVE BLADDER: SACRAL NEUROMODULATION VS. BOTULINUM TOXIN ASSESSMENT (ROSETTA)

被引：0
|
作者：
Amundsen, C. [1 ]
Richter, H. [2 ]
Menefee, S. [3 ]
Komesu, Y. [4 ]
Arya, L. [5 ]
Gregory, W. T. [6 ]
Myers, D. [7 ]
Zyczynski, H. [8 ]
Vasavada, S. [9 ]
Nolen, T. [10 ]
Wallace, D. [10 ]
Meikle, S. [11 ]
机构：
[1] Duke Univ, Durham, NC 27706 USA
[2] Univ Alabama, Tuscaloosa, AL 35487 USA
[3] Kaiser Permanente San Diego, San Diego, CA USA
[4] Univ New Mexico, Albuquerque, NM 87131 USA
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] Oregon Hlth & Sci Univ, Portland, OR USA
[7] Brown Univ, Providence, RI 02912 USA
[8] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[9] Cleveland Clin, Cleveland, OH 44106 USA
[10] RTI Int, Res Triangle Pk, NC USA
[11] NICHD, Bethesda, MD USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2016年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [21] A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CARE
    Ganz, M.
    Clemens, J. Q.
    Anger, J.
    Denevich, S.
    Shah, D.
    Carlson, A.
    Wittek, M. R.
    Pashos, C.
    VALUE IN HEALTH, 2011, 14 (03) : A76 - A77
  • [22] Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare System
    Maria Paola Bertapelle
    Mario Vottero
    Giulio Del Popolo
    Marco Mencarini
    Edoardo Ostardo
    Michele Spinelli
    Antonella Giannantoni
    Anna D’Ausilio
    World Journal of Urology, 2015, 33 : 1109 - 1117
  • [23] INITIAL ASSESSMENT OF CHANGE IN SEXUAL FUNCTION WITH SACRAL NEUROMODULATION FOR REFRACTORY OVERACTIVE BLADDER
    Gill, Bradley C.
    Swartz, Mia A.
    Moore, Courtenay K.
    Rackley, Raymond R.
    Vasavada, Sandip P.
    Goldman, Howard B.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 145 - 146
  • [24] Botulinum toxin as a treatment for refractory overactive bladder
    Harris, Shatril
    Rizzolo, Denise
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (02):
  • [25] Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder
    Leong, Randall K.
    de Wachter, Stephan G. G.
    Joore, Manuela A.
    van Kerrebroeck, Philip E. V.
    BJU INTERNATIONAL, 2011, 108 (04) : 558 - 564
  • [26] IMPACT OF SACRAL NEUROMODULATION ON HRQOL IN PATIENTS WITH REFRACTORY OVERACTIVE BLADDER
    Angela, Cerruto Maria
    Anila, Minja
    Pierpaolo, Curti
    Carolina, D'Elia
    Antonio, D'Amico
    Sofia, Cardarelli
    Walter, Artibani
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 : S30 - S30
  • [27] OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder
    Siegel, Steven
    JOURNAL OF UROLOGY, 2017, 197 (01): : 11 - 12
  • [28] THE COST-UTILITY OF SACRAL NEUROMODULATION VERSUS BOTULINUM TOXIN A FOR THE TREATMENT OF REFRACTORY IDIOPATHIC OVERACTIVE BLADDER (WITH URGENCY URINARY INCONTINENCE) IN SWEDEN
    Borisenko, O.
    Reimer, E.
    Colpan, Z.
    Petkovski, A.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S239 - S240
  • [29] TREATMENT OUTCOMES IN PARKINSON'S DISEASE-RELATED OVERACTIVE BLADDER: SACRAL NEUROMODULATION VS. ONABOTULINUMA TOXIN INJECTIONS
    Haile, Eiftu
    Chow, Po-Ming
    Goldman, Howard
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1225 - E1225
  • [30] Sacral Neuromodulation for Refractory Overactive Bladder, Interstitial Cystitis, and Painful Bladder Syndrome
    Laviana, Aaron
    Jellison, Forrest
    Kim, Ja-Hong
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2014, 25 (01) : 33 - +
12345